| 2026年中报 | 2025年年报 | 2025年中报 | 2024年年报 | 2024年中报 | |
|---|---|---|---|---|---|
| 营业收入(元) | |||||
| 医药业务(元) | 175,838,921.44 | - | 203,398,935.91 | - | 217,081,895.31 |
| 粉针产品(元) | - | 31,437,582.92 | - | 38,911,302.25 | - |
| 口服溶液产品(元) | - | 84,372,780.99 | - | 96,793,713.39 | - |
| 中小针剂产品(元) | - | 259,349,731.51 | - | 240,135,421.69 | - |
| 颗粒剂及其他产品(元) | - | 18,414,166.23 | - | 21,298,213.31 | - |
| 营业成本(元) | |||||
| 医药业务(元) | 31,849,346.42 | - | 35,705,499.57 | - | 44,277,177.30 |
| 粉针产品(元) | - | 9,879,183.37 | - | 17,050,550.96 | - |
| 口服溶液产品(元) | - | 24,484,756.25 | - | 26,591,893.01 | - |
| 中小针剂产品(元) | - | 28,994,588.52 | - | 26,640,898.21 | - |
| 颗粒剂及其他产品(元) | - | 13,572,094.58 | - | 15,197,379.66 | - |
| 毛利(元) | |||||
| 医药业务(元) | 143,989,575.02 | - | 167,693,436.34 | - | 172,804,718.01 |
| 粉针产品(元) | - | 21,558,399.55 | - | 21,860,751.29 | - |
| 口服溶液产品(元) | - | 59,888,024.74 | - | 70,201,820.38 | - |
| 中小针剂产品(元) | - | 230,355,142.99 | - | 213,494,523.48 | - |
| 颗粒剂及其他产品(元) | - | 4,842,071.65 | - | 6,100,833.65 | - |
| 毛利率(%) | |||||
| 医药业务(%) | 81.89 | - | 82.45 | - | 79.60 |
| 粉针产品(%) | - | 68.58 | - | 56.18 | - |
| 口服溶液产品(%) | - | 70.98 | - | 72.53 | - |
| 中小针剂产品(%) | - | 88.82 | - | 88.91 | - |
| 颗粒剂及其他产品(%) | - | 26.30 | - | 28.64 | - |
| 收入构成(%) | |||||
| 医药业务(%) | 100.00 | - | 100.00 | - | 100.00 |
| 粉针产品(%) | - | 7.99 | - | 9.80 | - |
| 口服溶液产品(%) | - | 21.44 | - | 24.37 | - |
| 中小针剂产品(%) | - | 65.90 | - | 60.47 | - |
| 颗粒剂及其他产品(%) | - | 4.68 | - | 5.36 | - |
| 毛利构成(%) | |||||
| 医药业务(%) | 100.00 | - | 100.00 | - | 100.00 |
| 粉针产品(%) | - | 6.81 | - | 7.01 | - |
| 口服溶液产品(%) | - | 18.91 | - | 22.53 | - |
| 中小针剂产品(%) | - | 72.75 | - | 68.50 | - |
| 颗粒剂及其他产品(%) | - | 1.53 | - | 1.96 | - |